BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Meng ZW, Han SH, Zhu JH, Zhou LY, Chen YL. Risk Factors for Cholangiocarcinoma After Initial Hepatectomy for Intrahepatic Stones. World J Surg. 2017;41:835-843. [PMID: 27766397 DOI: 10.1007/s00268-016-3752-2] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Ma H, Li W, Bi P, Wang Q, Li J, Yang B. hsa-miR-93 regulates MUCIN family gene expression via WNT/β-catenin pathway in intrahepatic stone disease. Clinics and Research in Hepatology and Gastroenterology 2018;42:453-61. [DOI: 10.1016/j.clinre.2018.03.013] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
2 Meng ZW, Pan W, Hong HJ, Chen JZ, Chen YL. Modified staging classification for intrahepatic cholangiocarcinoma based on the sixth and seventh editions of the AJCC/UICC TNM staging systems. Medicine (Baltimore) 2017;96:e7891. [PMID: 28834905 DOI: 10.1097/MD.0000000000007891] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 2.2] [Reference Citation Analysis]
3 Meng Z, Lin X, Zhu J, Han S, Chen Y. A nomogram to predict lymph node metastasis before resection in intrahepatic cholangiocarcinoma. Journal of Surgical Research 2018;226:56-63. [DOI: 10.1016/j.jss.2018.01.024] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 2.5] [Reference Citation Analysis]
4 Meng ZW, Pan W, Hong HJ, Chen JZ, Chen YL. Macroscopic types of intrahepatic cholangiocarcinoma and the eighth edition of AJCC/UICC TNM staging system. Oncotarget. 2017;8:101165-101174. [PMID: 29254154 DOI: 10.18632/oncotarget.20932] [Cited by in Crossref: 21] [Cited by in F6Publishing: 19] [Article Influence: 4.2] [Reference Citation Analysis]
5 Chen B, Fu SW, Lu L, Zhao H. A Preliminary Study of Biliary Microbiota in Patients with Bile Duct Stones or Distal Cholangiocarcinoma. Biomed Res Int 2019;2019:1092563. [PMID: 31662965 DOI: 10.1155/2019/1092563] [Cited by in Crossref: 9] [Cited by in F6Publishing: 13] [Article Influence: 3.0] [Reference Citation Analysis]
6 Liu B, Cao PK, Wang YZ, Wang WJ, Tian SL, Hertzanu Y, Li YL. Modified percutaneous transhepatic papillary balloon dilation for patients with refractory hepatolithiasis. World J Gastroenterol 2020; 26(27): 3929-3937 [PMID: 32774067 DOI: 10.3748/wjg.v26.i27.3929] [Cited by in CrossRef: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
7 Gan L, Pan S, Cui J, Bai J, Jiang P, He Y. Functional analysis of the correlation between ABCB11 gene mutation and primary intrahepatic stone. Mol Med Rep 2019;19:195-204. [PMID: 30431138 DOI: 10.3892/mmr.2018.9661] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
8 Suzuki Y, Mori T, Momose H, Matsuki R, Kogure M, Abe N, Isayama H, Tazuma S, Tanaka A, Takikawa H, Sakamoto Y. Predictive factors for subsequent intrahepatic cholangiocarcinoma associated with hepatolithiasis: Japanese National Cohort Study for 18 years. J Gastroenterol 2022. [PMID: 35357571 DOI: 10.1007/s00535-022-01868-6] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
9 Kim HJ, Kang TU, Swan H, Kang MJ, Kim N, Ahn HS, Park SM. Incidence and Prognosis of Subsequent Cholangiocarcinoma in Patients with Hepatic Resection for Bile Duct Stones. Dig Dis Sci. 2018;63:3465-3473. [PMID: 30171402 DOI: 10.1007/s10620-018-5262-6] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
10 Xu X, Zheng L, Hang N, Zhu G, Mao W, Fan Y, Tao K. The transcription factor c-Jun regulates Smad4 expression by upregulating pre-miR-183 expression to promote invasion and metastasis of esophageal squamous cell carcinomas. In Vitro Cell Dev Biol Anim 2020;56:550-8. [PMID: 32886291 DOI: 10.1007/s11626-020-00499-6] [Reference Citation Analysis]